CAMBRIDGE, Mass., Mar 28, 2002 (BUSINESS WIRE) -- Alkermes, Inc. (NASDAQ: ALKS) will be providing a live webcast of a meeting at which management of the company will review the company's business strategy, the recent merger announcement with Reliant Pharmaceuticals, Inc., pipeline progress and drug development operations. Alkermes invites investors and the general public to listen to this live webcast on April 2, 2002 beginning at 10:00am ET. The webcast can be accessed by going to the Alkermes website at www.alkermes.com and clicking on the investor relations tab. This webcast will not be archived.
Alkermes is a leader in the development of products based on sophisticated drug delivery technologies. The Company has several areas of focus including (i) controlled, sustained-release of injectable drugs lasting several days to several weeks using its ProLease(R) and Medisorb(R) technologies and (ii) the development of pharmaceutical products based on its proprietary AIR(TM) pulmonary technology. In addition to the Company's Cambridge, Massachusetts headquarters, research and manufacturing facilities, Alkermes operates research and manufacturing facilities in Ohio and a medical affairs office in Cambridge, England.
CONTACT: Alkermes, Inc.
Rebecca Peterson
Director, Investor Relations
(617) 583-6378